Pneumococcal vaccine for risk groups 2024 (2025, 2026 and 2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Pneumococcal Vaccines for risk groups belonging to the National Vaccination Programme in Finland. The contract period is about one year 2024. The procurement contains three options to extend the contract for the periods 2025, 2026 and 2027. Estimated quantity for the contract period depends on the tendered price since the total price for procurement is fixed and the total cost for this procurement is 650,000.00 euros (excluding VAT) for the contract period. Estimated quantity for the option periods is about half of the annual amount for the contract period. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Minimum Requirements Concerning the Subject of Procurement Pneumococcal Vaccine for Risk Groups Annex 2 JYSE 2014 Supplies (updated version of April 2022) Annex 3 Handi Annex 4 The Rationale for Pneumococcal Vaccine Procurement Tender Criteria Annex 5 Price Form Annex 6 Contract

The purpose of STM and the Customer is to procure Pneumococcal Vaccines for risk groups required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for patients 74-year-old and under according to vaccine's Summary of Product Characteristics (SPC). Target group for risk group vaccinations is patients under 75-year-old with severe chronic disease (for example kidney disease or severe lung disease). Finnish Institute for Health and Welfare reserves the right to change and update the definition of risk groups when needed. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. CONTRACT PERIOD The contract´s duration is about one year 2024. Estimated quantity for the contract period depends on the tendered price since the total price for procurement is fixed and the total cost for this procurement is 650,000.00 euros (excluding VAT) for the contract period. The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tender.

Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the Call for tender refer to local time in Finland.

This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tenders and its Annexes.